Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

References for PMC Articles for PubMed (Select 22431901)

1.

Continuation of statin therapy in patients with presumed infection: a randomized controlled trial.

Kruger PS, Harward ML, Jones MA, Joyce CJ, Kostner KM, Roberts MS, Venkatesh B.

Am J Respir Crit Care Med. 2011 Mar 15;183(6):774-81. doi: 10.1164/rccm.201006-0955OC. Epub 2010 Oct 19.

PMID:
20959555
2.

A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Ridker PM.

N Engl J Med. 2009 Apr 30;360(18):1851-61. doi: 10.1056/NEJMoa0900241. Epub 2009 Mar 29.

3.

Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.

Myles PR, Hubbard RB, McKeever TM, Pogson Z, Smith CJ, Gibson JE.

Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):269-75. doi: 10.1002/pds.1715.

PMID:
19235776
4.

The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial.

Novack V, Eisinger M, Frenkel A, Terblanche M, Adhikari NK, Douvdevani A, Amichay D, Almog Y.

Intensive Care Med. 2009 Jul;35(7):1255-60. doi: 10.1007/s00134-009-1429-0. Epub 2009 Feb 11.

PMID:
19205663
5.

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group.

N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.

6.

Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients.

Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sørensen HT.

Arch Intern Med. 2008 Oct 27;168(19):2081-7. doi: 10.1001/archinte.168.19.2081.

PMID:
18955636
7.

Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect.

Brookhart MA, Patrick AR, Dormuth C, Avorn J, Shrank W, Cadarette SM, Solomon DH.

Am J Epidemiol. 2007 Aug 1;166(3):348-54. Epub 2007 May 15.

8.

Statins and the risk of pneumonia: a population-based, nested case-control study.

Schlienger RG, Fedson DS, Jick SS, Jick H, Meier CR.

Pharmacotherapy. 2007 Mar;27(3):325-32.

PMID:
17316144
9.

The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases.

Almog Y, Novack V, Eisinger M, Porath A, Novack L, Gilutz H.

Crit Care Med. 2007 Feb;35(2):372-8.

PMID:
17205009
10.

Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study.

Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ.

BMJ. 2006 Nov 11;333(7576):999. Epub 2006 Oct 23.

11.

Statin treatment and reduced risk of pneumonia in patients with diabetes.

van de Garde EM, Hak E, Souverein PC, Hoes AW, van den Bosch JM, Leufkens HG.

Thorax. 2006 Nov;61(11):957-61. Epub 2006 Jun 29.

12.

Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis.

Hackam DG, Mamdani M, Li P, Redelmeier DA.

Lancet. 2006 Feb 4;367(9508):413-8.

PMID:
16458766
13.

Anti-inflammatory effects of statins: clinical evidence and basic mechanisms.

Jain MK, Ridker PM.

Nat Rev Drug Discov. 2005 Dec;4(12):977-87. Review.

PMID:
16341063
14.

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators.

Lancet. 2005 Oct 8;366(9493):1267-78. Epub 2005 Sep 27. Erratum in: Lancet. 2008 Jun 21;371(9630):2084. Lancet. 2005 Oct 15-21;366(9494):1358.

PMID:
16214597
15.

Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism.

Glynn RJ, Rosner B.

Am J Epidemiol. 2005 Nov 15;162(10):975-82. Epub 2005 Oct 5.

16.
17.

Statin treatment after onset of sepsis in a murine model improves survival.

Merx MW, Liehn EA, Graf J, van de Sandt A, Schaltenbrand M, Schrader J, Hanrath P, Weber C.

Circulation. 2005 Jul 5;112(1):117-24.

18.

Prior statin therapy is associated with a decreased rate of severe sepsis.

Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, Friger M, Zeller L, Danon A.

Circulation. 2004 Aug 17;110(7):880-5. Epub 2004 Aug 2.

19.

Ways of measuring rates of recurrent events.

Glynn RJ, Buring JE.

BMJ. 1996 Feb 10;312(7027):364-7. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk